Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Bnp Paribas Arbitrage, Snc
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Bnp Paribas Arbitrage, Snc
from 13F filings
Historical chart of Bnp Paribas Arbitrage, Snc investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Bnp Paribas Arbitrage, Snc
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $41M | 25M | 1.64 |
| 2025-06-30 | $22M | 17M | 1.30 |
| 2025-03-31 | $6.4M | 5.5M | 1.15 |
| 2024-12-31 | $8.2M | 7.8M | 1.06 |
| 2024-09-30 | $8.3M | 7.1M | 1.17 |
| 2024-06-30 | $5.1M | 4.7M | 1.08 |
| 2024-03-31 | $21k | 22k | 0.94 |
| 2023-12-31 | $1.5M | 1.5M | 0.98 |
More positions owned by Bnp Paribas Arbitrage, Snc
View all positions for Bnp Paribas Arbitrage, Snc
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1